Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Motorcyclist Injured in Crash on Interstate 105 Near Wilmington Avenue


Motorcycle, Tow Truck Collide in Los Angeles Accident

Los Angeles, CA (April 14, 2020) – A motorcyclist was injured in a crash in Los Angeles. The accident occurred on the morning of April 14 on Interstate 105.

A motorcycle was heading east on the 105 Freeway, near Wilmington Avenue, when it rear-ended a tow truck. The motorcycle rider was injured in the crash and treated by emergency crews.

#Los Angeles

#90002


May 14, 2020

Woman Injured in Crash on Highway 62 and Lee Drive

Vehicle Hits Victim in Twentynine Palms Accident...


December 11, 2019

Edward Albano Killed in Pedestrian Crash on Temple Avenue

Man Hit by Car in Fatal Pomona Accident...


November 29, 2019

1 Injured in Crash on Highway 395 Near Sherwin Summit

2 Vehicles Involved in Bishop Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.